Today: 23 May 2026
Bank of America stock rises as yields edge up; what could move BAC next week
3 January 2026
1 min read

Bank of America stock rises as yields edge up; what could move BAC next week

NEW YORK, Jan 3, 2026, 1:55 PM ET — Market closed

Bank of America Corp (NYSE: BAC) shares rose 1.73% to close at $55.95 on Friday, tracking gains across major U.S. banks. JPMorgan Chase climbed 1.01%, Wells Fargo gained 2.15% and Citigroup added 1.72%, according to MarketWatch data.

The move came as Treasury yields pushed higher, a shift that often matters for bank stocks because it can change the economics of lending. The benchmark 10-year yield rose 3.8 basis points — a basis point is one-hundredth of a percentage point — to 4.191%, while the 30-year yield climbed to 4.8682%, Reuters reported.

The Dow and S&P 500 ended higher on Friday while the Nasdaq slipped slightly, snapping a four-session losing streak for the blue-chip and broad indexes. With markets closed for the weekend, traders are looking ahead to next week’s labor-market data and the Federal Reserve’s rate outlook. Joe Mazzola, head of trading and derivatives strategist at Charles Schwab, said the mood has been “buy the dip, sell the rip.” Reuters

Bank stocks often react quickly to shifts in the yield curve — the gap between long-term and short-term rates — because it influences lending profitability. A steeper curve can help interest earnings, while higher funding costs can offset the benefit.

A filing on Friday showed BofA Finance LLC, backed by a Bank of America guarantee, marketed auto-callable enhanced return notes tied to the least-performing of the Nasdaq-100, Russell 2000 and S&P 500 indexes, due Feb. 1, 2029. Auto-callable notes can repay early if preset thresholds are met; if the worst-performing index drops far enough, investors can lose principal. The preliminary pricing supplement said the notes are expected to price on Jan. 27 and issue on Jan. 30.

Analysts tracked by MarketWatch put a median target of $59 on Bank of America, above current levels. Their estimates ranged from $53 to $68.

Before the next session, investors will parse the U.S. Employment Situation report for December 2025, due at 8:30 a.m. ET on Jan. 9, for clues on wages and hiring.

Inflation is next. The U.S. Consumer Price Index for December 2025 is scheduled for 8:30 a.m. ET on Jan. 13, a release that can swing Treasury yields and, by extension, bank stocks.

Bank of America is due to report fourth-quarter 2025 results on Jan. 14, and it expects to release the numbers around 6:45 a.m. ET and hold an investor call at 8:30 a.m. ET, the bank said. Traders will listen for updated expectations on credit losses, deposit costs and net interest income.

From a technical standpoint, Bank of America shares are near the top of their 52-week range of $33.07 to $56.55. Friday’s trading range of $54.88 to $55.99 kept the $56 area in focus ahead of next week’s data and the start of bank earnings season.

Stock Market Today

  • UBS Boosts Jazz Pharma Stock Price Target to $307 Ahead of FDA Decision
    May 23, 2026, 2:29 PM EDT. UBS upgraded Jazz Pharmaceuticals (JAZZ) stock from neutral to buy, raising its price target by 63% to $307 from $188. This surge exceeds the prior consensus of $242 and follows strong Q1 results, with revenue up 19% year-over-year and oncology portfolio growth of 45%. The move anticipates FDA approval on August 25 of Zanidatamab (Ziihera) for HER2-positive gastroesophageal cancer, expected to generate peak sales of $3.1 billion. UBS projects 10% revenue and 11% earnings growth from 2026-2030, versus consensus of around 7% and 6%, and supports a valuation multiple increase from 7x to 10x earnings, reflecting confidence in sustainable growth. Key risks include FDA delays, slower oncology sales ramp, and underperformance of core franchises like Xywav and Epidiolex.

Latest articles

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

AbbVie Shares Edge Up Ahead Of Holiday On Pipeline News

23 May 2026
AbbVie shares closed Friday at $215.70, up 0.56%, gaining 2.5% for the week. The company reported a positive European panel recommendation for MAVIRET in acute hepatitis C and released new oncology data ahead of the ASCO meeting. U.S. markets are closed Monday for Memorial Day, with trading set to resume Tuesday.
Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

Coherent Shares Trade Close to $378, With Next Test Set for Tuesday After Volatile AI-Optics Week

23 May 2026
Coherent Corp. shares closed at $377.57 Friday, down 0.1% for the day and 1.3% below last week, underperforming the S&P 500 and Nasdaq ahead of the Memorial Day market closure. The company reported fiscal Q3 revenue of $1.81 billion, up 21% year-over-year, with strong demand in datacenter and communications. Nvidia invested $2 billion in March and signed a multi-year optics agreement. Coherent trades at 179 times trailing earnings.
Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

Intuit Slashes 3,000 Jobs as TurboTax Faces New AI Threats

23 May 2026
Intuit will cut about 3,000 jobs, or 17% of its workforce, and close offices in Reno and Woodland Hills as it restructures to focus on artificial intelligence. The company expects $300 million to $340 million in charges, mostly in the fiscal fourth quarter. Intuit raised full-year revenue guidance but lowered its TurboTax outlook, citing pressure from low-cost AI tools. Shares last traded at $319.94 after a volatile week.
Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains
Previous Story

Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom
Next Story

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom

Go toTop